Kremer Hovinga, Johanna Anna

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006

2017

Scully, M; Cataland, S; Coppo, P; de la Rubia, J; Friedman, K D; Kremer Hovinga, Johanna Anna; Lämmle, Bernhard; Matsumoto, M; Pavenski, K; Sadler, E; Sarode, R; Wu, H (2017). Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. Journal of thrombosis and haemostasis, 15(2), pp. 312-322. Wiley 10.1111/jth.13571

Kremer Hovinga, Johanna Anna (2017). Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. In: Gresele, Paolo; Kleiman, Neal S.; Lopez, José A.; Page, Clive P. (eds.) Platelets in Thrombotic and Non-Thrombotic Disorders (pp. 851-871). Springer 10.1007/978-3-319-47462-5_57

2016

Kölm, Robert; Schaller Tschan, Monica; Roumenina, Lubka T; Niemiec, Iga; Kremer Hovinga, Johanna Anna; Khanicheh, Elham; Kaufmann, Beat A; Hopfer, Helmut; Trendelenburg, Marten (2016). Von Willebrand Factor Interacts with Surface-Bound C1q and Induces Platelet Rolling. Journal of immunology, 197(9), pp. 3669-3679. American Association of Immunologists 10.4049/jimmunol.1501876

Page, Evaren E; Kremer Hovinga, Johanna Anna; Terrell, Deirdra R; Vesely, Sara K; George, James N (2016). Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura. Blood, 128(17), pp. 2175-2178. American Society of Hematology 10.1182/blood-2016-06-724161

Nagler, Michael; Kremer Hovinga, Johanna Anna; Alberio, Lorenzo; Peter-Salonen, Kristiina; Von Tengg-Kobligk, Hendrik; Lottaz, Daniel; Neerman-Arbez, Marguerite; Lämmle, Bernhard (2016). Thromboembolism in patients with congenital afibrinogenaemia. Long-term observational data and systematic review. Thrombosis and haemostasis, 116(4), pp. 722-732. Schattauer 10.1160/TH16-02-0082

Pavenski, Katerina; Cataland, Spero; Kremer Hovinga, Johanna Anna; Thomas, Mari; Vanhoorelbeke, Karen (2016). Thrombotic thrombocytopenic pupura (TTP) dinner symposium proceedings. Expert review of hematology, 9(8), pp. 733-735. Expert Reviews 10.1080/17474086.2016.1198895

Pedrazzini, Giovanni; Biasco, Luigi; Sulzer, Irmela; Anesini, Adriana; Moccetti, Tiziano; Kremer Hovinga, Johanna Anna; Alberio, Lorenzo (2016). Acquired intracoronary ADAMTS13 deficiency and VWF retention at sites of critical coronary stenosis in patients with STEMI. Blood, 127(23), pp. 2934-2936. American Society of Hematology 10.1182/blood-2015-12-688010

Page, Evaren E; Kremer Hovinga, Johanna Anna; Terrell, Deirdra R; Vesely, Sara K; George, James N (2016). Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura. Blood, 127(24), pp. 3092-3094. American Society of Hematology 10.1182/blood-2016-03-703827

Fan, Xinping; Kremer Hovinga, Johanna Anna; Shirotani-Ikejima, Hiroko; Eura, Yuka; Hirai, Hidenori; Honda, Shigenori; Kokame, Koichi; Mansouri Taleghani, Magnus; von Krogh, Anne-Sophie; Yoshida, Yoko; Fujimura, Yoshihiro; Lämmle, Bernhard; Miyata, Toshiyuki (2016). Genetic variations in complement factors in patients with congenital thrombotic thrombocytopenic purpura with renal insufficiency. International journal of hematology, 103(3), pp. 283-291. Springer 10.1007/s12185-015-1933-7

Peyvandi, Flora; Scully, Marie; Kremer Hovinga, Johanna Anna; Cataland, Spero; Knöbl, Paul; Wu, Haifeng; Artoni, Andrea; Westwood, John-Paul; Mansouri Taleghani, Magnus; Jilma, Bernd; Callewaert, Filip; Ulrichts, Hans; Duby, Christian; Tersago, Dominique (2016). Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. The New England journal of medicine, 374(6), pp. 511-522. Massachusetts Medical Society 10.1056/NEJMoa1505533

von Krogh, A S; Quist-Paulsen, P; Waage, A; Langseth, Ø O; Thorstensen, K; Brudevold, R; Tjønnfjord, G E; Largiadèr, Carlo Rodolfo; Lämmle, Bernhard; Kremer Hovinga, Johanna Anna (2016). High prevalence of hereditary thrombotic thrombocytopenic purpura in Central Norway: from clinical observation to evidence. Journal of thrombosis and haemostasis, 14(1), pp. 73-82. Blackwell 10.1111/jth.13186

Engert, A.; Balduini, C.; Brand, A.; Coiffier, B.; Cordonnier, C.; Dohner, H.; de Wit, T. D.; Eichinger, S.; Fibbe, W.; Green, T.; de Haas, F.; Iolascon, A.; Jaffredo, T.; Rodeghiero, F.; Salles, G.; Schuringa, J. J.; EHA, Roadmap for European Hematology Research; Kremer Hovinga, Johanna Anna; von Gunten, Stephan (2016). The European Hematology Association Roadmap for European Hematology Research: a consensus document. Haematologica - the hematology journal, 101(2), pp. 115-208. Ferrata-Storti Foundation 10.3324/haematol.2015.136739

Kremer Hovinga, Johanna Anna (2016). 111 années après Alexis Nikolaïevitch Romanov, guérison de l’hémophilie B sévère en perspective. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 16(1), pp. 9-11. EMH Editores Medicorum Helveticorum

2015

von Krogh, Anne-Sophie; Kremer Hovinga, Johanna Anna; Romundstad, Pål R; Roten, Linda T; Lämmle, Bernhard; Waage, Anders; Quist-Paulsen, Petter (2015). ADAMTS13 gene variants and function in women with preeclampsia: a population- based nested case- control study from the HUNT Study. Thrombosis research, 136(2), pp. 282-288. Elsevier 10.1016/j.thromres.2015.06.022

Hubbard, A R; Heath, A B; Kremer Hovinga, Johanna Anna (2015). Establishment of the WHO 1st International Standard ADAMTS13, plasma (12/252): communication from the SSC of the ISTH. Journal of thrombosis and haemostasis, 13(6), pp. 1151-1153. Blackwell 10.1111/jth.12881

Arni, Delphine; Gumy-Pause, Fabienne; Ansari, Marc; Kremer Hovinga, Johanna Anna; McLin, Valérie A (2015). Successful liver transplantation in a child with acute-on-chronic liver failure and acquired thrombotic thrombocytopenic purpura. Liver transplantation, 21(5), pp. 704-706. Wiley 10.1002/lt.24096

von Auer, Charis; von Krogh, Anne-Sophie; Kremer Hovinga, Johanna Anna; Lämmle, Bernhard (2015). Current insights into thrombotic microangiopathies: Thrombotic thrombocytopenic purpura and pregnancy. Thrombosis research, 135(Suppl1), S30-S33. Elsevier 10.1016/S0049-3848(15)50437-4

Raval, Jay S.; Padmanabhan, Anand; Kremer Hovinga, Johanna Anna; Kiss, Joseph E. (2015). Development of a clinically significant ADAMTS13 inhibitor in a patient with hereditary thrombotic thrombocytopenic purpura. American journal of hematology, 90(1), E22-E22. Wiley-Liss 10.1002/ajh.23851

Jiménez-Alcázar, M; Napirei, M; Panda, R; Köhler, E C; Kremer Hovinga, Johanna Anna; Mannherz, H G; Peine, S; Renné, T; Lämmle, Bernhard; Fuchs, T A (2015). Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies. Journal of thrombosis and haemostasis, 13(5), pp. 732-742. Blackwell 10.1111/jth.12796

Edgar, Contessa E; Terrell, Deirdra R; Vesely, Sara K; Wren, Jonathan D; Dozmorov, Igor M; Niewold, Timothy B; Brown, Michael; Zhou, Fang; Frank, Mark Barton; Merrill, Joan T; Kremer Hovinga, Johanna Anna; Lämmle, Bernhard; James, Judith A; George, James N; Farris, A Darise (2015). Ribosomal and Immune Transcripts Associate with Relapse in Acquired ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura. PLoS ONE, 10(2), e0117614. Public Library of Science 10.1371/journal.pone.0117614

2014

Schaller Tschan, Monica; Vogel, Monique; Kentouche, Karim; Lämmle, Bernhard; Kremer Hovinga, Johanna Anna (2014). The splenic autoimmune response to ADAMTS13 in thrombotic thrombocytopenic purpura contains recurrent antigen-binding CDR3 motifs. Blood, 124(23), pp. 3469-3479. American Society of Hematology 10.1182/blood-2014-04-561142

Adler, Marcel; Kremer Hovinga, Johanna Anna; Lämmle, Bernhard (2014). Le purpura thrombotique thrombocytopénique - un diagtnostic méconnu. Revue médicale suisse, pp. 2280-2284. Médecine & Hygiène

Jiang, Yang; McIntosh, Jennifer J; Reese, Jessica A; Deford, Cassandra C; Kremer Hovinga, Johanna Anna; Lämmle, Bernhard; Terrell, Deirdra R; Vesely, Sara K; Knudtson, Eric J; George, James N (2014). Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood, 123(11), pp. 1674-80. American Society of Hematology 10.1182/blood-2013-11-538900

Falter, T; Kremer Hovinga, Johanna Anna; Lackner, K; Füllemann, H-G; Lämmle, Bernhard; Scharrer, I (2014). Late onset and pregnancy-induced congenital thrombotic thrombocytopenic purpura. Hämostaseologie, 34(3), pp. 244-248. Schattauer 10.5482/HAMO-14-03-0023

von Krogh, Anne-Sophie; Kremer Hovinga, Johanna Anna; Tjønnfjord, Geir E.; Ringen, Ingrid M.; Lämmle, Bernhard; Waage, Anders; Quist-Paulsen, Petter (2014). The impact of congenital thrombotic thrombocytopenic purpura on pregnancy complications. Thrombosis and haemostasis, 111(6), pp. 1180-1183. Schattauer 10.1160/TH13-08-0713

Rank, Cecilie Utke; Kremer Hovinga, Johanna Anna; Mansouri Taleghani, Magnus; Lämmle, Bernhard; Gøtze, Jens Peter; Nielsen, Ove Juul (2014). Congenital thrombotic thrombocytopenic purpura caused by new compound heterozygous mutations of the ADAMTS13 gene. European journal of haematology, 92(2), pp. 168-171. Wiley-Blackwell 10.1111/ejh.12197

Ferrari, Silvia; Palavra, Kristina; Gruber, Bernadette; Kremer Hovinga, Johanna Anna; Knöbl, Paul; Caron, Claudine; Cromwell, Caroline; Aledort, Louis; Plaimauer, Barbara; Turecek, Peter L.; Rottensteiner, Hanspeter; Scheiflinger, Friedrich (2014). Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura. Haematologica - the hematology journal, 99(4), pp. 779-787. Ferrata-Storti Foundation 10.3324/haematol.2013.094151

2013

Diaz, Jose Antonio; Fuchs, Tobias A.; Jackson, Tatum O.; Kremer Hovinga, Johanna A.; Lämmle, Bernhard; Henke, Peter K.; Myers, Daniel D.; Wagner, Denisa D.; Wakefield, Thomas W.; Michigan Research Venous Group, for the (2013). Plasma DNA is Elevated in Patients with Deep Vein Thrombosis. Journal of vascular surgery. Venous and lymphatic disorder, 1(4), 341-348.e1. Elsevier 10.1016/j.jvsv.2012.12.002

Reese, Jessica A.; Muthurajah, Darrshini S.; Kremer Hovinga, Johanna A.; Vesely, Sara K.; Terrell, Deirdra R.; George, James N. (2013). Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatric blood & cancer, 60(10), pp. 1676-1682. Wiley-Liss 10.1002/pbc.24612

Deford, Cassandra C.; Reese, Jessica A.; Schwartz, Lauren H.; Perdue, Jedidiah J.; Kremer Hovinga, Johanna Anna; Lämmle, Bernhard; Terrell, Deirdra R.; Vesely, Sara K.; George, James N. (2013). Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood, 122(12), pp. 2023-2029. American Society of Hematology 10.1182/blood-2013-04-496752

Deal, Taylor; Kremer Hovinga, Johanna A.; Marques, Marisa B.; Adamski, Jill (2013). Novel ADAMTS13 mutations in an obstetric patient with upshaw-schulman syndrome. Journal of clinical apheresis, 28(4), pp. 311-316. New York, N.Y.: Wiley-Liss 10.1002/jca.21251

Mansouri Taleghani, Magnus; von Krogh, A.-S.; Fujimura, Y.; George, J. N.; Hrachovinová, I.; Knöbl, P. N.; Quist-Paulsen, P.; Schneppenheim, R.; Lämmle, Bernhard; Kremer Hovinga, Johanna Anna (2013). Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry. Hämostaseologie, 33(2), pp. 138-43. Schattauer 10.5482/HAMO-13-04-0026

Kremer Hovinga, Johanna Anna (2013). Thrombotic microangiopathies. Hämostaseologie, 33(2), p. 81. Schattauer

Schaller, Monica; Studt, J.-D.; Voorberg, J.; Kremer Hovinga, Johanna Anna (2013). Acquired thrombotic thrombocytopenic purpura. Development of an autoimmune response. Hämostaseologie, 33(2), pp. 121-30. Schattauer 10.5482/HAMO-12-12-0023

Hausammann, Stefanie; Vogel, Monique; Kremer Hovinga, Johanna A.; Lacroix-Desmazes, Sebastien; Stadler, Beda M.; Horn, Michael P. (2013). Designed ankyrin repeat proteins: a new approach to mimic complex antigens for diagnostic purposes? PLoS ONE, 8(4), e60688. Public Library of Science 10.1371/journal.pone.0060688

2012

Du, Vivian X; van Os, Gwen; Kremer Hovinga, Johanna A; Dienava-Verdoold, Ilze; Wollersheim, Jacques; Ruggeri, Zaverio M; Fijnheer, Rob; de Groot, Philip G; de Laat, Bas (2012). Indications for a protective function of beta2-glycoprotein I in thrombotic thrombocytopenic purpura. British journal of haematology, 159(1), pp. 94-103. Oxford: Wiley-Blackwell 10.1111/bjh.12004

Fuchs, Tobias A; Kremer Hovinga, Johanna A; Schatzberg, Daphne; Wagner, Denisa D; Lämmle, Bernhard (2012). Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood, 120(6), pp. 1157-64. Washington, D.C.: American Society of Hematology 10.1182/blood-2012-02-412197

Kremer Hovinga, Johanna A; Voorberg, Jan (2012). Improving on nature: redesigning ADAMTS13. Blood, 119(16), pp. 3654-5. Washington, D.C.: American Society of Hematology 10.1182/blood-2012-02-410431

Som, Sumit; Deford, Cassandra C; Kaiser, Mandi L; Terrell, Deirdra R; Kremer Hovinga, Johanna A; Lämmle, Bernhard; George, James N; Vesely, Sara K (2012). Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion, 52(12), 2525-32; quiz 2524. Malden, Mass.: Wiley-Blackwell 10.1046/j.1537-2995.2000.40080896.x

George, James N; Terrell, Deirdra R; Vesely, Sara K; Kremer Hovinga, Johanna A; Lämmle, Bernhard (2012). Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. Presse médicale, 41(3 Pt 2), e177-88. Issy-les-Moulineaux (F): Elsevier Masson SAS 10.1016/j.lpm.2011.10.026

Kremer Hovinga, Johanna A; Lämmle, Bernhard (2012). Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. Hematology, 2012, pp. 610-616. Washington, D.C.: American Society of Hematology 10.1182/asheducation-2012.1.610

2011

Froehlich-Zahnd, Rahel; George, James N; Vesely, Sara K; Terrell, Deirdra R; Aboulfatova, Khatira; Dong, Jing-Fei; Luken, Brenda M; Voorberg, Jan; Budde, Ulrich; Sulzer, Irmela; Lämmle, Bernhard; Kremer Hovinga, Johanna A (2011). Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica - the hematology journal, 97(2), pp. 297-303. Pavia: Ferrata-Storti Foundation

Jahns, Maximilian; Friess, Dorothea; Demarmels Biasiutti, Franziska; Kremer Hovinga, Johanna A; Alberio, Lorenzo; Oldenburg, Johannes; Lämmle, Bernhard; Colucci, Giuseppe (2011). Massive muscle haematoma three months after starting vitamin K antagonist therapy for deep-vein thrombosis in an antithrombin deficient patient: another case of factor IX propeptide mutation. Thrombosis and haemostasis, 106(2), pp. 381-2. Stuttgart: Schattauer 10.1160/TH11-03-0191

Terrell, Deirdra R; Motto, David G; Kremer Hovinga, Johanna A; Lämmle, Bernhard; George, James N; Vesely, Sara K (2011). Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. Transfusion, 51(10), pp. 2237-43. Malden, Mass.: Wiley-Blackwell 10.1111/j.1537-2995.2011.03125.x

Plaimauer, B; Kremer Hovinga, J A; Juno, C; Wolfsegger, M J; Skalicky, S; Schmidt, M; Grillberger, L; Hasslacher, M; Knöbl, P; Ehrlich, H; Scheiflinger, F (2011). Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies. Journal of thrombosis and haemostasis, 9(5), pp. 936-44. Oxford: Blackwell 10.1111/j.1538-7836.2011.04224.x

Pos, W; Luken, B M; Sorvillo, N; Hovinga, J A Kremer; Voorberg, J (2011). Humoral immune response to ADAMTS13 in acquired thrombotic thrombocytopenic purpura. Journal of thrombosis and haemostasis, 9(7), pp. 1285-91. Oxford: Blackwell 10.1111/j.1538-7836.2011.04307.x

2010

Terrell, Deirdra R; Vesely, Sara K; Hovinga, Johanna A Kremer; Lämmle, Bernhard; George, James N (2010). Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. American journal of hematology, 85(11), pp. 844-7. New York, N.Y.: Wiley-Liss 10.1002/ajh.21833

Hovinga, Johanna A Kremer; Vesely, Sara K; Terrell, Deirdra R; Lämmle, Bernhard; George, James N (2010). Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood, 115(8), 1500-11; quiz 1662. Washington, D.C.: American Society of Hematology 10.1182/blood-2009-09-243790

2009

Benjamin, Melody; Terrell, Deirdra R; Vesely, Sara K; Voskuhl, Gene W; Dezube, Bruce J; Kremer Hovinga, Johanna A; Lämmle, Bernhard; George, James N (2009). Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clinical infectious diseases, 48(8), pp. 1129-37. Cary, N.C.: Oxford University Press 10.1086/597471

Kennedy, April S; Lewis, Qurana F; Scott, James G; Kremer Hovinga, Johanna A; Lämmle, Bernhard; Terrell, Deirdra R; Vesely, Sara K; George, James N (2009). Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion, 49(6), pp. 1092-101. Malden, Mass.: Wiley-Blackwell 10.1111/j.1537-2995.2009.02101.x

Swisher, Karen K; Terrell, Deirdra R; Vesely, Sara K; Kremer Hovinga, Johanna A; Lämmle, Bernhard; George, James N (2009). Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion, 49(5), pp. 873-87. Malden, Mass.: Wiley-Blackwell 10.1111/j.1537-2995.2008.02082.x

Ferrari, S; Mudde, G C; Rieger, M; Veyradier, A; Kremer Hovinga, J A; Scheiflinger, F (2009). IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura. Journal of thrombosis and haemostasis, 7(10), pp. 1703-10. Oxford: Blackwell 10.1111/j.1538-7836.2009.03568.x

Pos, W; Luken, B M; Hovinga, J A Kremer; Turenhout, E A M; Scheiflinger, F; Dong, J-F; Fijnheer, R; Voorberg, J (2009). VH1-69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura. Journal of thrombosis and haemostasis, 7(3), pp. 421-8. Oxford: Blackwell 10.1111/j.1538-7836.2008.03250.x

2008

Bergmann, I P; Kremer Hovinga, J A; Lämmle, B; Peter, H J; Schiemann, U (2008). Acute pancreatitis and thrombotic thrombocytopenic purpura. European journal of medical research, 13(10), pp. 481-2. München: I. Holzapfel

Tripodi, A; Peyvandi, F; Chantarangkul, V; Palla, R; Afrasiabi, A; Canciani, M T; Chung, D W; Ferrari, S; Fujimura, Y; Karimi, M; Kokame, K; Kremer Hovinga, J A; Lämmle, B; de Meyer, S F; Plaimauer, B; Vanhoorelbeke, K; Varadi, K; Mannucci, P M (2008). Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13). Journal of thrombosis and haemostasis, 6(9), pp. 1534-41. Oxford: Blackwell 10.1111/j.1538-7836.2008.03099.x

Karpac, Charity A; Li, Xiaoning; Terrell, Deirdra R; Kremer Hovinga, Johanna A; Lämmle, Bernhard; Vesely, Sara K; George, James N (2008). Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. British journal of haematology, 141(5), pp. 696-707. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2008.07116.x

Lämmle, Bernhard; Kremer Hovinga, Johanna A; George, James N (2008). Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease. Haematologica - the hematology journal, 93(2), pp. 172-7. Pavia: Ferrata-Storti Foundation 10.3324/haemato.12701

Meyer, Sara C; Jeddi, Ramzi; Meddeb, Balkis; Gouider, Emna; Lämmle, Bernhard; Kremer Hovinga, Johanna A (2008). A first case of congenital TTP on the African continent due to a new homozygous mutation in the catalytic domain of ADAMTS13. Annals of hematology, 87(8), pp. 663-6. Berlin: Springer 10.1007/s00277-008-0496-6

George, James N; Kremer Hovinga, Johanna A; Terrell, Deirdra R; Vesely, Sara K; Lämmle, Bernhard (2008). The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection. European journal of haematology, 80(4), pp. 277-86. Oxford: Wiley-Blackwell 10.1111/j.1600-0609.2008.01040.x

Kremer Hovinga, Johanna A; Meyer, Sara C (2008). Current management of thrombotic thrombocytopenic purpura. Current opinion in hematology, 15(5), pp. 445-50. Hagerstown, Md.: Wolters Kluwer Lippincott Williams & Wilkins 10.1097/MOH.0b013e328309ec62

2007

Rüfer, Axel; Brodmann, Doreen; Gregor, Michael; Kremer Hovinga, Johanna A; Lämmle, Bernhard; Wuillemin, Walter A (2007). Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature. Swiss medical weekly, 137(37-38), pp. 518-24. Muttenz: EMH Schweizerischer Ärzteverlag

Kremer Hovinga, J A; Zeerleder, S; Kessler, P; Romani de Wit, T; van Mourik, J A; Hack, C E; ten Cate, H; Reitsma, P H; Wuillemin, W A; Lämmle, B (2007). ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock. Journal of thrombosis and haemostasis, 5(11), pp. 2284-90. Oxford: Blackwell 10.1111/j.1538-7836.2007.02743.x

Swisher, Karen K; Doan, John T; Vesely, Sara K; Kwaan, Hau C; Kim, Benjamin; Laemmle, Bernhard; Kremer Hovinga, Johanna A; George, James N (2007). Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica - the hematology journal, 92(7), pp. 936-43. Pavia: Ferrata-Storti Foundation 10.3324/haematol.10963

Meyer, S C; Sulzer, I; Lämmle, B; Kremer Hovinga, J A (2007). Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies. Journal of thrombosis and haemostasis, 5(4), pp. 866-7. Oxford: Blackwell 10.1111/j.1538-7836.2007.02438.x

2006

Lämmle, B; Kremer Hovinga, J A (2006). A new tool to further explore the role of ADAMTS-13 in health and disease. Journal of thrombosis and haemostasis, 4(5), pp. 952-4. Oxford: Blackwell 10.1111/j.1538-7836.2006.01945.x

Fontana, S; Kremer Hovinga, J A; Lämmle, B; Mansouri Taleghani, B (2006). Treatment of thrombotic thrombocytopenic purpura. Vox sanguinis, 90(4), pp. 245-54. Oxford: Wiley-Blackwell 10.1111/j.1423-0410.2006.00747.x

Kremer Hovinga, J A; Mottini, M; Lämmle, B (2006). Measurement of ADAMTS-13 activity in plasma by the FRETS-VWF73 assay: comparison with other assay methods. Journal of thrombosis and haemostasis, 4(5), pp. 1146-8. Oxford: Blackwell 10.1111/j.1538-7836.2006.01904.x

Luken, B M; Kaijen, P H P; Turenhout, E A M; Kremer Hovinga, J A; van Mourik, J A; Fijnheer, R; Voorberg, J (2006). Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura. Journal of thrombosis and haemostasis, 4(11), pp. 2355-64. Oxford: Blackwell 10.1111/j.1538-7836.2006.02164.x

Schneppenheim, Reinhard; Kremer Hovinga, Johanna A; Becker, Tim; Budde, Ulrich; Karpman, Diana; Brockhaus, Wolfgang; Hrachovinová, Ingrid; Korczowski, Bartosz; Oyen, Florian; Rittich, Simon; von Rosen, Johannes; Tjønnfjord, Geir E; Pimanda, John E; Wienker, Thomas F; Lämmle, Bernhard (2006). A common origin of the 4143insA ADAMTS13 mutation. Thrombosis and haemostasis, 96(1), pp. 3-6. Stuttgart: Schattauer 10.1160/TH05-12-0817

Schnog, JJ; Hovinga, JA; Krieg, S; Akin, S; Lämmle, B; Brandjes, DP; Mac Gillavry, MR; Muskiet, FD; Duits, AJ; CURAMA, Study Group (2006). ADAMTS13 activity in sickle cell disease. American journal of hematology, 81(7), pp. 492-8. New York, N.Y.: Wiley-Liss 10.1002/ajh.20653

Provide Feedback